Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Unit 097
Houston, TX 77030Phone+1 713-563-2300Fax+1 713-563-2366- Is this information wrong?
Education & Training
- Johns Hopkins UniversityResidency, Radiation Oncology, 2005 - 2009
- Loma Linda University Health Education ConsortiumInternship, Internal Medicine, 2004 - 2005
- University of California, Irvine, School of MedicineClass of 2004
Certifications & Licensure
- FL State Medical License 2021 - Present
- CA State Medical License 2006 - 2025
- TX State Medical License 2009 - 2025
- GA State Medical License 2023 - 2025
- LA State Medical License 2023 - 2024
- MS State Medical License 2023 - 2024
- AL State Medical License 2023 - 2024
- American Board of Radiology Radiation Oncology
- Join now to see all
Clinical Trials
- Trimodality Management of T1b Esophageal Cancers Start of enrollment: 2010 Oct 01
- A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer Start of enrollment: 2013 Feb 01
- Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2013 Oct 28
- Join now to see all
Publications & Presentations
PubMed
- Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable local...Kelsey L Corrigan, Ting Xu, Yuki Sasaki, Ruitao Lin, Aileen B Chen, James W Welsh, Steven H Lin, Joe Y Chang, Matthew S Ning, Saumil Gandhi, Michael S O'Reilly, Carl M...> ;Radiotherapy and Oncology. 2024 Apr 1
- BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1.Young-Seung Kim, Seung-Hoon Lee, Andrew H Park, Chunai Wu, Bong-Ki Hong, Hyunjin Jung, Stephen S Yoo, Steven H Lin> ;Journal for Immunotherapy of Cancer. 2024 Mar 14
- Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort St...D'Aiello, A., Owen, D. H., Amin H Nassar, So Yeon Kim, Jacqueline V Aredo, Jamie Feng, Frances Shepherd, Chao Xu, David Kaldas, Jhanelle E Gray, Thomas J Dilling, Joel...> ;Journal of Thoracic Oncology. 2024 Jan 24
- Join now to see all
Journal Articles
- Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveill...Hong Yang, Steven H Lin, Annals of Surgical Oncology
- Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?☆Zhongxing Liao, Saumil J Gandhi, Steven H Lin, ScienceDirect
Press Mentions
- Dr. Lin on Combination Atezolizumab and Chemoradiation in Locally Advanced NSCLCJune 10th, 2019
- Multi-Institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and OutcomesJanuary 12th, 2018
- Novel Radiation Therapy Techniques Should Become Standard in Esophageal Cancer ManagementApril 17th, 2017
- Join now to see all
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: